Relay Therapeutics, Inc. RLAY
16.93 USD -0.34 (-2.00%)
As ofNov 17, 2026, 11:14 AM EST
16.75 Day range 17.42
6.25 52-week range 21.27
- YTD
- +100.06%
- 1 year
- +155.66%
RLAY revenue history
Revenue is income from the company’s ordinary business activities.
15,355,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 15,355,000 | 5,348,000 | 53.44% |
| FY 2024 | 2024-12-31 | 10,007,000 | -15,539,000 | -60.83% |
| FY 2023 | 2023-12-31 | 25,546,000 | 24,165,000 | 1749.82% |
| FY 2022 | 2022-12-31 | 1,381,000 | -1,648,000 | -54.41% |
| FY 2021 | 2021-12-31 | 3,029,000 | -79,625,000 | -96.34% |
| FY 2020 | 2020-12-31 | 82,654,000 | 82,654,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:24:18.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
